Global Dog Vaccine

Dog Vaccine Comprehensive Study by Type (Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Therapeutic Biologics, Others), Vaccine Consumption (Less than 6 Months, More than 6 Months), Vaccinations (Rabies, Distemper, Hepatitis/Adenovirus, Parvovirus, Parainfluenza, Others) Players and Region - Global Market Outlook to 2028

Dog Vaccine Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Dog Vaccine
Vaccination plays a central role in protecting dogs from major canine infectious diseases. These include viral and bacterial diseases, which are can cause significant illness and are difficult to treat. Dogs are susceptible to a range of infectious diseases that can have a serious effect on their health and welfare. A vaccine usually contains an agent that resembles a disease-causing microorganism and killed forms of the microbe, its toxins, or its surface proteins. Vaccination plays a central role in protecting dogs from major canine infectious diseases. These include viral and bacterial diseases, which are can cause significant illness and are difficult to treat. Dogs are susceptible to a range of infectious diseases that can have a serious effect on their health and welfare.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Dog Vaccine market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bayer AG (Germany), Sanofi (France), Elanco Animal Health (United States), Merck Sharp & Dohme Corp (United States), Virbac (France), Zoetis (United States), Phibro Animal Health Corporation (United States), Boehringer Ingelheim GmbH (Germany), Tianjin Ringpu Bio-Technology Co., Ltd (China), Vetoquinol (France) and Indian Immunologicals Ltd. (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Ceva (United States), Anicon Labor (Germany), Nexvet (Australia) and Vaxxinova International B V (Netherlands).

Segmentation Overview
AMA Research has segmented the market of Global Dog Vaccine market by Type (Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Therapeutic Biologics and Others) and Region.



On the basis of geography, the market of Dog Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Vaccine Consumption, the sub-segment i.e. Less than 6 Months will boost the Dog Vaccine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Vaccinations, the sub-segment i.e. Rabies will boost the Dog Vaccine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Innovations in Vaccines

Market Growth Drivers:
Increasing Awareness Regarding Animal Health and Increasing Ownership of Pets

Challenges:
High Cost in Production of Veterinary Vaccines

Restraints:
Inactivated Vaccines are Less Immunogenic and Side Effects of Some Vaccines Such as Reactions or Allergies

Opportunities:
Growing Initiatives by Government Agencies and Animal Association

Market Leaders and their expansionary development strategies
On April 26, 2019- Elanco Animal Health has announced that it has signed an agreement to acquire Aratana Therapeutics, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Galliprant. and On June 04, 2019- Boehringer Ingelheim has partnered with Constantia Flexibles to provide veterinarians and horse owners with Constantia Interactive, an innovative packaging solution which enhances the Nutraxin packaging with augmented reality features.
In May 2023, Zoetis Inc. the U.S. Food and Drug Administration (FDA) has approved Librela™ (bedinvetmab injection) for the control of pain associated with osteoarthritis (OA) in dogs. Librela is the first and only once-monthly, anti-NGF monoclonal antibody treatment for canine OA pain and is approved as safe and effective in providing long-term control of OA pain symptoms in dogs, which can improve their mobility and overall quality of life.
California Rabies Law- The main law can be found in the California Health and Safety Code, which is a set of state laws governing public wellbeing. The rabies law requires dog owners to obtain a new dog license at least every two years, starting once the dog is four months old. Dogs younger than four months do not have to be licensed. and Indiana Rabies Laws and Regulations- 345 IAC 1-5-2 Required rabies vaccination of dogs, cats, and ferrets (Section 2) all dogs, cats, and ferrets three (3) months of age and older must be vaccinated against rabies. The rabies vaccination of a dog, cat, and ferret shall be maintained by ongoing revaccination of the animal.

Key Target Audience
Manufacturers of Animal Vaccine, Suppliers of Animal Vaccine, Wholesalers, Distributors and Retailers of Animal Vaccine, Animal Welfare Associations, Veterinary Clinics and Care Centers and Governmental Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Therapeutic Biologics
  • Others
By Vaccine Consumption
  • Less than 6 Months
  • More than 6 Months

By Vaccinations
  • Rabies
  • Distemper
  • Hepatitis/Adenovirus
  • Parvovirus
  • Parainfluenza
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness Regarding Animal Health
      • 3.2.2. Increasing Ownership of Pets
    • 3.3. Market Challenges
      • 3.3.1. High Cost in Production of Veterinary Vaccines
    • 3.4. Market Trends
      • 3.4.1. Technological Innovations in Vaccines
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dog Vaccine, by Type, Vaccine Consumption, Vaccinations and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Dog Vaccine (Value)
      • 5.2.1. Global Dog Vaccine by: Type (Value)
        • 5.2.1.1. Attenuated Live Vaccines
        • 5.2.1.2. Inactivated Vaccines
        • 5.2.1.3. Toxoid Vaccines
        • 5.2.1.4. Recombinant Vaccines
        • 5.2.1.5. Therapeutic Biologics
        • 5.2.1.6. Others
      • 5.2.2. Global Dog Vaccine by: Vaccine Consumption (Value)
        • 5.2.2.1. Less than 6 Months
        • 5.2.2.2. More than 6 Months
      • 5.2.3. Global Dog Vaccine by: Vaccinations (Value)
        • 5.2.3.1. Rabies
        • 5.2.3.2. Distemper
        • 5.2.3.3. Hepatitis/Adenovirus
        • 5.2.3.4. Parvovirus
        • 5.2.3.5. Parainfluenza
        • 5.2.3.6. Others
      • 5.2.4. Global Dog Vaccine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Dog Vaccine (Volume)
      • 5.3.1. Global Dog Vaccine by: Type (Volume)
        • 5.3.1.1. Attenuated Live Vaccines
        • 5.3.1.2. Inactivated Vaccines
        • 5.3.1.3. Toxoid Vaccines
        • 5.3.1.4. Recombinant Vaccines
        • 5.3.1.5. Therapeutic Biologics
        • 5.3.1.6. Others
      • 5.3.2. Global Dog Vaccine by: Vaccine Consumption (Volume)
        • 5.3.2.1. Less than 6 Months
        • 5.3.2.2. More than 6 Months
      • 5.3.3. Global Dog Vaccine by: Vaccinations (Volume)
        • 5.3.3.1. Rabies
        • 5.3.3.2. Distemper
        • 5.3.3.3. Hepatitis/Adenovirus
        • 5.3.3.4. Parvovirus
        • 5.3.3.5. Parainfluenza
        • 5.3.3.6. Others
      • 5.3.4. Global Dog Vaccine Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Dog Vaccine (Price)
      • 5.4.1. Global Dog Vaccine by: Type (Price)
  • 6. Dog Vaccine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elanco Animal Health (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck Sharp & Dohme Corp (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Virbac (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Zoetis (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Phibro Animal Health Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Boehringer Ingelheim GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tianjin Ringpu Bio-Technology Co., Ltd (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vetoquinol (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Indian Immunologicals Ltd. (India)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Dog Vaccine Sale, by Type, Vaccine Consumption, Vaccinations and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Dog Vaccine (Value)
      • 7.2.1. Global Dog Vaccine by: Type (Value)
        • 7.2.1.1. Attenuated Live Vaccines
        • 7.2.1.2. Inactivated Vaccines
        • 7.2.1.3. Toxoid Vaccines
        • 7.2.1.4. Recombinant Vaccines
        • 7.2.1.5. Therapeutic Biologics
        • 7.2.1.6. Others
      • 7.2.2. Global Dog Vaccine by: Vaccine Consumption (Value)
        • 7.2.2.1. Less than 6 Months
        • 7.2.2.2. More than 6 Months
      • 7.2.3. Global Dog Vaccine by: Vaccinations (Value)
        • 7.2.3.1. Rabies
        • 7.2.3.2. Distemper
        • 7.2.3.3. Hepatitis/Adenovirus
        • 7.2.3.4. Parvovirus
        • 7.2.3.5. Parainfluenza
        • 7.2.3.6. Others
      • 7.2.4. Global Dog Vaccine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Dog Vaccine (Volume)
      • 7.3.1. Global Dog Vaccine by: Type (Volume)
        • 7.3.1.1. Attenuated Live Vaccines
        • 7.3.1.2. Inactivated Vaccines
        • 7.3.1.3. Toxoid Vaccines
        • 7.3.1.4. Recombinant Vaccines
        • 7.3.1.5. Therapeutic Biologics
        • 7.3.1.6. Others
      • 7.3.2. Global Dog Vaccine by: Vaccine Consumption (Volume)
        • 7.3.2.1. Less than 6 Months
        • 7.3.2.2. More than 6 Months
      • 7.3.3. Global Dog Vaccine by: Vaccinations (Volume)
        • 7.3.3.1. Rabies
        • 7.3.3.2. Distemper
        • 7.3.3.3. Hepatitis/Adenovirus
        • 7.3.3.4. Parvovirus
        • 7.3.3.5. Parainfluenza
        • 7.3.3.6. Others
      • 7.3.4. Global Dog Vaccine Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Dog Vaccine (Price)
      • 7.4.1. Global Dog Vaccine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dog Vaccine: by Type(USD Million)
  • Table 2. Dog Vaccine Attenuated Live Vaccines , by Region USD Million (2017-2022)
  • Table 3. Dog Vaccine Inactivated Vaccines , by Region USD Million (2017-2022)
  • Table 4. Dog Vaccine Toxoid Vaccines , by Region USD Million (2017-2022)
  • Table 5. Dog Vaccine Recombinant Vaccines , by Region USD Million (2017-2022)
  • Table 6. Dog Vaccine Therapeutic Biologics , by Region USD Million (2017-2022)
  • Table 7. Dog Vaccine Others , by Region USD Million (2017-2022)
  • Table 8. Dog Vaccine: by Vaccine Consumption(USD Million)
  • Table 9. Dog Vaccine Less than 6 Months , by Region USD Million (2017-2022)
  • Table 10. Dog Vaccine More than 6 Months , by Region USD Million (2017-2022)
  • Table 11. Dog Vaccine: by Vaccinations(USD Million)
  • Table 12. Dog Vaccine Rabies , by Region USD Million (2017-2022)
  • Table 13. Dog Vaccine Distemper , by Region USD Million (2017-2022)
  • Table 14. Dog Vaccine Hepatitis/Adenovirus , by Region USD Million (2017-2022)
  • Table 15. Dog Vaccine Parvovirus , by Region USD Million (2017-2022)
  • Table 16. Dog Vaccine Parainfluenza , by Region USD Million (2017-2022)
  • Table 17. Dog Vaccine Others , by Region USD Million (2017-2022)
  • Table 18. South America Dog Vaccine, by Country USD Million (2017-2022)
  • Table 19. South America Dog Vaccine, by Type USD Million (2017-2022)
  • Table 20. South America Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 21. South America Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 22. Brazil Dog Vaccine, by Type USD Million (2017-2022)
  • Table 23. Brazil Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 24. Brazil Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 25. Argentina Dog Vaccine, by Type USD Million (2017-2022)
  • Table 26. Argentina Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 27. Argentina Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 28. Rest of South America Dog Vaccine, by Type USD Million (2017-2022)
  • Table 29. Rest of South America Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 30. Rest of South America Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 31. Asia Pacific Dog Vaccine, by Country USD Million (2017-2022)
  • Table 32. Asia Pacific Dog Vaccine, by Type USD Million (2017-2022)
  • Table 33. Asia Pacific Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 34. Asia Pacific Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 35. China Dog Vaccine, by Type USD Million (2017-2022)
  • Table 36. China Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 37. China Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 38. Japan Dog Vaccine, by Type USD Million (2017-2022)
  • Table 39. Japan Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 40. Japan Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 41. India Dog Vaccine, by Type USD Million (2017-2022)
  • Table 42. India Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 43. India Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 44. South Korea Dog Vaccine, by Type USD Million (2017-2022)
  • Table 45. South Korea Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 46. South Korea Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 47. Taiwan Dog Vaccine, by Type USD Million (2017-2022)
  • Table 48. Taiwan Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 49. Taiwan Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 50. Australia Dog Vaccine, by Type USD Million (2017-2022)
  • Table 51. Australia Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 52. Australia Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Dog Vaccine, by Type USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 55. Rest of Asia-Pacific Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 56. Europe Dog Vaccine, by Country USD Million (2017-2022)
  • Table 57. Europe Dog Vaccine, by Type USD Million (2017-2022)
  • Table 58. Europe Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 59. Europe Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 60. Germany Dog Vaccine, by Type USD Million (2017-2022)
  • Table 61. Germany Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 62. Germany Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 63. France Dog Vaccine, by Type USD Million (2017-2022)
  • Table 64. France Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 65. France Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 66. Italy Dog Vaccine, by Type USD Million (2017-2022)
  • Table 67. Italy Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 68. Italy Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 69. United Kingdom Dog Vaccine, by Type USD Million (2017-2022)
  • Table 70. United Kingdom Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 71. United Kingdom Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 72. Netherlands Dog Vaccine, by Type USD Million (2017-2022)
  • Table 73. Netherlands Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 74. Netherlands Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 75. Rest of Europe Dog Vaccine, by Type USD Million (2017-2022)
  • Table 76. Rest of Europe Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 77. Rest of Europe Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 78. MEA Dog Vaccine, by Country USD Million (2017-2022)
  • Table 79. MEA Dog Vaccine, by Type USD Million (2017-2022)
  • Table 80. MEA Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 81. MEA Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 82. Middle East Dog Vaccine, by Type USD Million (2017-2022)
  • Table 83. Middle East Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 84. Middle East Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 85. Africa Dog Vaccine, by Type USD Million (2017-2022)
  • Table 86. Africa Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 87. Africa Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 88. North America Dog Vaccine, by Country USD Million (2017-2022)
  • Table 89. North America Dog Vaccine, by Type USD Million (2017-2022)
  • Table 90. North America Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 91. North America Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 92. United States Dog Vaccine, by Type USD Million (2017-2022)
  • Table 93. United States Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 94. United States Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 95. Canada Dog Vaccine, by Type USD Million (2017-2022)
  • Table 96. Canada Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 97. Canada Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 98. Mexico Dog Vaccine, by Type USD Million (2017-2022)
  • Table 99. Mexico Dog Vaccine, by Vaccine Consumption USD Million (2017-2022)
  • Table 100. Mexico Dog Vaccine, by Vaccinations USD Million (2017-2022)
  • Table 101. Dog Vaccine Sales: by Type(ml)
  • Table 102. Dog Vaccine Sales Attenuated Live Vaccines , by Region ml (2017-2022)
  • Table 103. Dog Vaccine Sales Inactivated Vaccines , by Region ml (2017-2022)
  • Table 104. Dog Vaccine Sales Toxoid Vaccines , by Region ml (2017-2022)
  • Table 105. Dog Vaccine Sales Recombinant Vaccines , by Region ml (2017-2022)
  • Table 106. Dog Vaccine Sales Therapeutic Biologics , by Region ml (2017-2022)
  • Table 107. Dog Vaccine Sales Others , by Region ml (2017-2022)
  • Table 108. Dog Vaccine Sales: by Vaccine Consumption(ml)
  • Table 109. Dog Vaccine Sales Less than 6 Months , by Region ml (2017-2022)
  • Table 110. Dog Vaccine Sales More than 6 Months , by Region ml (2017-2022)
  • Table 111. Dog Vaccine Sales: by Vaccinations(ml)
  • Table 112. Dog Vaccine Sales Rabies , by Region ml (2017-2022)
  • Table 113. Dog Vaccine Sales Distemper , by Region ml (2017-2022)
  • Table 114. Dog Vaccine Sales Hepatitis/Adenovirus , by Region ml (2017-2022)
  • Table 115. Dog Vaccine Sales Parvovirus , by Region ml (2017-2022)
  • Table 116. Dog Vaccine Sales Parainfluenza , by Region ml (2017-2022)
  • Table 117. Dog Vaccine Sales Others , by Region ml (2017-2022)
  • Table 118. South America Dog Vaccine Sales, by Country ml (2017-2022)
  • Table 119. South America Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 120. South America Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 121. South America Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 122. Brazil Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 123. Brazil Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 124. Brazil Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 125. Argentina Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 126. Argentina Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 127. Argentina Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 128. Rest of South America Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 129. Rest of South America Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 130. Rest of South America Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 131. Asia Pacific Dog Vaccine Sales, by Country ml (2017-2022)
  • Table 132. Asia Pacific Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 133. Asia Pacific Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 134. Asia Pacific Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 135. China Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 136. China Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 137. China Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 138. Japan Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 139. Japan Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 140. Japan Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 141. India Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 142. India Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 143. India Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 144. South Korea Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 145. South Korea Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 146. South Korea Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 147. Taiwan Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 148. Taiwan Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 149. Taiwan Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 150. Australia Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 151. Australia Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 152. Australia Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 153. Rest of Asia-Pacific Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 154. Rest of Asia-Pacific Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 155. Rest of Asia-Pacific Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 156. Europe Dog Vaccine Sales, by Country ml (2017-2022)
  • Table 157. Europe Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 158. Europe Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 159. Europe Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 160. Germany Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 161. Germany Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 162. Germany Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 163. France Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 164. France Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 165. France Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 166. Italy Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 167. Italy Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 168. Italy Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 169. United Kingdom Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 170. United Kingdom Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 171. United Kingdom Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 172. Netherlands Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 173. Netherlands Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 174. Netherlands Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 175. Rest of Europe Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 176. Rest of Europe Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 177. Rest of Europe Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 178. MEA Dog Vaccine Sales, by Country ml (2017-2022)
  • Table 179. MEA Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 180. MEA Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 181. MEA Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 182. Middle East Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 183. Middle East Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 184. Middle East Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 185. Africa Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 186. Africa Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 187. Africa Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 188. North America Dog Vaccine Sales, by Country ml (2017-2022)
  • Table 189. North America Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 190. North America Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 191. North America Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 192. United States Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 193. United States Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 194. United States Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 195. Canada Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 196. Canada Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 197. Canada Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 198. Mexico Dog Vaccine Sales, by Type ml (2017-2022)
  • Table 199. Mexico Dog Vaccine Sales, by Vaccine Consumption ml (2017-2022)
  • Table 200. Mexico Dog Vaccine Sales, by Vaccinations ml (2017-2022)
  • Table 201. Dog Vaccine: by Type(USD/Units)
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Dog Vaccine: by Type(USD Million)
  • Table 214. Dog Vaccine Attenuated Live Vaccines , by Region USD Million (2023-2028)
  • Table 215. Dog Vaccine Inactivated Vaccines , by Region USD Million (2023-2028)
  • Table 216. Dog Vaccine Toxoid Vaccines , by Region USD Million (2023-2028)
  • Table 217. Dog Vaccine Recombinant Vaccines , by Region USD Million (2023-2028)
  • Table 218. Dog Vaccine Therapeutic Biologics , by Region USD Million (2023-2028)
  • Table 219. Dog Vaccine Others , by Region USD Million (2023-2028)
  • Table 220. Dog Vaccine: by Vaccine Consumption(USD Million)
  • Table 221. Dog Vaccine Less than 6 Months , by Region USD Million (2023-2028)
  • Table 222. Dog Vaccine More than 6 Months , by Region USD Million (2023-2028)
  • Table 223. Dog Vaccine: by Vaccinations(USD Million)
  • Table 224. Dog Vaccine Rabies , by Region USD Million (2023-2028)
  • Table 225. Dog Vaccine Distemper , by Region USD Million (2023-2028)
  • Table 226. Dog Vaccine Hepatitis/Adenovirus , by Region USD Million (2023-2028)
  • Table 227. Dog Vaccine Parvovirus , by Region USD Million (2023-2028)
  • Table 228. Dog Vaccine Parainfluenza , by Region USD Million (2023-2028)
  • Table 229. Dog Vaccine Others , by Region USD Million (2023-2028)
  • Table 230. South America Dog Vaccine, by Country USD Million (2023-2028)
  • Table 231. South America Dog Vaccine, by Type USD Million (2023-2028)
  • Table 232. South America Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 233. South America Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 234. Brazil Dog Vaccine, by Type USD Million (2023-2028)
  • Table 235. Brazil Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 236. Brazil Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 237. Argentina Dog Vaccine, by Type USD Million (2023-2028)
  • Table 238. Argentina Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 239. Argentina Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 240. Rest of South America Dog Vaccine, by Type USD Million (2023-2028)
  • Table 241. Rest of South America Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 242. Rest of South America Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 243. Asia Pacific Dog Vaccine, by Country USD Million (2023-2028)
  • Table 244. Asia Pacific Dog Vaccine, by Type USD Million (2023-2028)
  • Table 245. Asia Pacific Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 246. Asia Pacific Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 247. China Dog Vaccine, by Type USD Million (2023-2028)
  • Table 248. China Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 249. China Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 250. Japan Dog Vaccine, by Type USD Million (2023-2028)
  • Table 251. Japan Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 252. Japan Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 253. India Dog Vaccine, by Type USD Million (2023-2028)
  • Table 254. India Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 255. India Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 256. South Korea Dog Vaccine, by Type USD Million (2023-2028)
  • Table 257. South Korea Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 258. South Korea Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 259. Taiwan Dog Vaccine, by Type USD Million (2023-2028)
  • Table 260. Taiwan Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 261. Taiwan Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 262. Australia Dog Vaccine, by Type USD Million (2023-2028)
  • Table 263. Australia Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 264. Australia Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 265. Rest of Asia-Pacific Dog Vaccine, by Type USD Million (2023-2028)
  • Table 266. Rest of Asia-Pacific Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 267. Rest of Asia-Pacific Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 268. Europe Dog Vaccine, by Country USD Million (2023-2028)
  • Table 269. Europe Dog Vaccine, by Type USD Million (2023-2028)
  • Table 270. Europe Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 271. Europe Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 272. Germany Dog Vaccine, by Type USD Million (2023-2028)
  • Table 273. Germany Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 274. Germany Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 275. France Dog Vaccine, by Type USD Million (2023-2028)
  • Table 276. France Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 277. France Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 278. Italy Dog Vaccine, by Type USD Million (2023-2028)
  • Table 279. Italy Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 280. Italy Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 281. United Kingdom Dog Vaccine, by Type USD Million (2023-2028)
  • Table 282. United Kingdom Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 283. United Kingdom Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 284. Netherlands Dog Vaccine, by Type USD Million (2023-2028)
  • Table 285. Netherlands Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 286. Netherlands Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 287. Rest of Europe Dog Vaccine, by Type USD Million (2023-2028)
  • Table 288. Rest of Europe Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 289. Rest of Europe Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 290. MEA Dog Vaccine, by Country USD Million (2023-2028)
  • Table 291. MEA Dog Vaccine, by Type USD Million (2023-2028)
  • Table 292. MEA Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 293. MEA Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 294. Middle East Dog Vaccine, by Type USD Million (2023-2028)
  • Table 295. Middle East Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 296. Middle East Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 297. Africa Dog Vaccine, by Type USD Million (2023-2028)
  • Table 298. Africa Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 299. Africa Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 300. North America Dog Vaccine, by Country USD Million (2023-2028)
  • Table 301. North America Dog Vaccine, by Type USD Million (2023-2028)
  • Table 302. North America Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 303. North America Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 304. United States Dog Vaccine, by Type USD Million (2023-2028)
  • Table 305. United States Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 306. United States Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 307. Canada Dog Vaccine, by Type USD Million (2023-2028)
  • Table 308. Canada Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 309. Canada Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 310. Mexico Dog Vaccine, by Type USD Million (2023-2028)
  • Table 311. Mexico Dog Vaccine, by Vaccine Consumption USD Million (2023-2028)
  • Table 312. Mexico Dog Vaccine, by Vaccinations USD Million (2023-2028)
  • Table 313. Dog Vaccine Sales: by Type(ml)
  • Table 314. Dog Vaccine Sales Attenuated Live Vaccines , by Region ml (2023-2028)
  • Table 315. Dog Vaccine Sales Inactivated Vaccines , by Region ml (2023-2028)
  • Table 316. Dog Vaccine Sales Toxoid Vaccines , by Region ml (2023-2028)
  • Table 317. Dog Vaccine Sales Recombinant Vaccines , by Region ml (2023-2028)
  • Table 318. Dog Vaccine Sales Therapeutic Biologics , by Region ml (2023-2028)
  • Table 319. Dog Vaccine Sales Others , by Region ml (2023-2028)
  • Table 320. Dog Vaccine Sales: by Vaccine Consumption(ml)
  • Table 321. Dog Vaccine Sales Less than 6 Months , by Region ml (2023-2028)
  • Table 322. Dog Vaccine Sales More than 6 Months , by Region ml (2023-2028)
  • Table 323. Dog Vaccine Sales: by Vaccinations(ml)
  • Table 324. Dog Vaccine Sales Rabies , by Region ml (2023-2028)
  • Table 325. Dog Vaccine Sales Distemper , by Region ml (2023-2028)
  • Table 326. Dog Vaccine Sales Hepatitis/Adenovirus , by Region ml (2023-2028)
  • Table 327. Dog Vaccine Sales Parvovirus , by Region ml (2023-2028)
  • Table 328. Dog Vaccine Sales Parainfluenza , by Region ml (2023-2028)
  • Table 329. Dog Vaccine Sales Others , by Region ml (2023-2028)
  • Table 330. South America Dog Vaccine Sales, by Country ml (2023-2028)
  • Table 331. South America Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 332. South America Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 333. South America Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 334. Brazil Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 335. Brazil Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 336. Brazil Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 337. Argentina Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 338. Argentina Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 339. Argentina Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 340. Rest of South America Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 341. Rest of South America Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 342. Rest of South America Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 343. Asia Pacific Dog Vaccine Sales, by Country ml (2023-2028)
  • Table 344. Asia Pacific Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 345. Asia Pacific Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 346. Asia Pacific Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 347. China Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 348. China Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 349. China Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 350. Japan Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 351. Japan Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 352. Japan Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 353. India Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 354. India Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 355. India Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 356. South Korea Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 357. South Korea Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 358. South Korea Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 359. Taiwan Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 360. Taiwan Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 361. Taiwan Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 362. Australia Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 363. Australia Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 364. Australia Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 365. Rest of Asia-Pacific Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 366. Rest of Asia-Pacific Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 367. Rest of Asia-Pacific Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 368. Europe Dog Vaccine Sales, by Country ml (2023-2028)
  • Table 369. Europe Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 370. Europe Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 371. Europe Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 372. Germany Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 373. Germany Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 374. Germany Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 375. France Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 376. France Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 377. France Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 378. Italy Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 379. Italy Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 380. Italy Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 381. United Kingdom Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 382. United Kingdom Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 383. United Kingdom Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 384. Netherlands Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 385. Netherlands Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 386. Netherlands Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 387. Rest of Europe Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 388. Rest of Europe Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 389. Rest of Europe Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 390. MEA Dog Vaccine Sales, by Country ml (2023-2028)
  • Table 391. MEA Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 392. MEA Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 393. MEA Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 394. Middle East Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 395. Middle East Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 396. Middle East Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 397. Africa Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 398. Africa Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 399. Africa Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 400. North America Dog Vaccine Sales, by Country ml (2023-2028)
  • Table 401. North America Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 402. North America Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 403. North America Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 404. United States Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 405. United States Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 406. United States Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 407. Canada Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 408. Canada Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 409. Canada Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 410. Mexico Dog Vaccine Sales, by Type ml (2023-2028)
  • Table 411. Mexico Dog Vaccine Sales, by Vaccine Consumption ml (2023-2028)
  • Table 412. Mexico Dog Vaccine Sales, by Vaccinations ml (2023-2028)
  • Table 413. Dog Vaccine: by Type(USD/Units)
  • Table 414. Research Programs/Design for This Report
  • Table 415. Key Data Information from Secondary Sources
  • Table 416. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dog Vaccine: by Type USD Million (2017-2022)
  • Figure 5. Global Dog Vaccine: by Vaccine Consumption USD Million (2017-2022)
  • Figure 6. Global Dog Vaccine: by Vaccinations USD Million (2017-2022)
  • Figure 7. South America Dog Vaccine Share (%), by Country
  • Figure 8. Asia Pacific Dog Vaccine Share (%), by Country
  • Figure 9. Europe Dog Vaccine Share (%), by Country
  • Figure 10. MEA Dog Vaccine Share (%), by Country
  • Figure 11. North America Dog Vaccine Share (%), by Country
  • Figure 12. Global Dog Vaccine: by Type ml (2017-2022)
  • Figure 13. Global Dog Vaccine: by Vaccine Consumption ml (2017-2022)
  • Figure 14. Global Dog Vaccine: by Vaccinations ml (2017-2022)
  • Figure 15. South America Dog Vaccine Share (%), by Country
  • Figure 16. Asia Pacific Dog Vaccine Share (%), by Country
  • Figure 17. Europe Dog Vaccine Share (%), by Country
  • Figure 18. MEA Dog Vaccine Share (%), by Country
  • Figure 19. North America Dog Vaccine Share (%), by Country
  • Figure 20. Global Dog Vaccine: by Type USD/Units (2017-2022)
  • Figure 21. Global Dog Vaccine share by Players 2022 (%)
  • Figure 22. Global Dog Vaccine share by Players (Top 3) 2022(%)
  • Figure 23. Global Dog Vaccine share by Players (Top 5) 2022(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Bayer AG (Germany) Revenue: by Geography 2022
  • Figure 27. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 28. Sanofi (France) Revenue: by Geography 2022
  • Figure 29. Elanco Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 30. Elanco Animal Health (United States) Revenue: by Geography 2022
  • Figure 31. Merck Sharp & Dohme Corp (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck Sharp & Dohme Corp (United States) Revenue: by Geography 2022
  • Figure 33. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 34. Virbac (France) Revenue: by Geography 2022
  • Figure 35. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 36. Zoetis (United States) Revenue: by Geography 2022
  • Figure 37. Phibro Animal Health Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Phibro Animal Health Corporation (United States) Revenue: by Geography 2022
  • Figure 39. Boehringer Ingelheim GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Boehringer Ingelheim GmbH (Germany) Revenue: by Geography 2022
  • Figure 41. Tianjin Ringpu Bio-Technology Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 42. Tianjin Ringpu Bio-Technology Co., Ltd (China) Revenue: by Geography 2022
  • Figure 43. Vetoquinol (France) Revenue, Net Income and Gross profit
  • Figure 44. Vetoquinol (France) Revenue: by Geography 2022
  • Figure 45. Indian Immunologicals Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 46. Indian Immunologicals Ltd. (India) Revenue: by Geography 2022
  • Figure 47. Global Dog Vaccine: by Type USD Million (2023-2028)
  • Figure 48. Global Dog Vaccine: by Vaccine Consumption USD Million (2023-2028)
  • Figure 49. Global Dog Vaccine: by Vaccinations USD Million (2023-2028)
  • Figure 50. South America Dog Vaccine Share (%), by Country
  • Figure 51. Asia Pacific Dog Vaccine Share (%), by Country
  • Figure 52. Europe Dog Vaccine Share (%), by Country
  • Figure 53. MEA Dog Vaccine Share (%), by Country
  • Figure 54. North America Dog Vaccine Share (%), by Country
  • Figure 55. Global Dog Vaccine: by Type ml (2023-2028)
  • Figure 56. Global Dog Vaccine: by Vaccine Consumption ml (2023-2028)
  • Figure 57. Global Dog Vaccine: by Vaccinations ml (2023-2028)
  • Figure 58. South America Dog Vaccine Share (%), by Country
  • Figure 59. Asia Pacific Dog Vaccine Share (%), by Country
  • Figure 60. Europe Dog Vaccine Share (%), by Country
  • Figure 61. MEA Dog Vaccine Share (%), by Country
  • Figure 62. North America Dog Vaccine Share (%), by Country
  • Figure 63. Global Dog Vaccine: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Bayer AG (Germany)
  • Sanofi (France)
  • Elanco Animal Health (United States)
  • Merck Sharp & Dohme Corp (United States)
  • Virbac (France)
  • Zoetis (United States)
  • Phibro Animal Health Corporation (United States)
  • Boehringer Ingelheim GmbH (Germany)
  • Tianjin Ringpu Bio-Technology Co., Ltd (China)
  • Vetoquinol (France)
  • Indian Immunologicals Ltd. (India)
Additional players considered in the study are as follows:
Ceva (United States) , Anicon Labor (Germany) , Nexvet (Australia) , Vaxxinova International B V (Netherlands)
Select User Access Type

Key Highlights of Report


Dec 2023 231 Pages 72 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dog Vaccine Quantitative research analysis
Global Dog Vaccine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bayer AG (Germany), Sanofi (France), Elanco Animal Health (United States), Merck Sharp & Dohme Corp (United States), Virbac (France), Zoetis (United States), Phibro Animal Health Corporation (United States), Boehringer Ingelheim GmbH (Germany), Tianjin Ringpu Bio-Technology Co., Ltd (China), Vetoquinol (France) and Indian Immunologicals Ltd. (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Innovations in Vaccines" is seen as one of major influencing trends for Dog Vaccine Market during projected period 2022-2028.
The Dog Vaccine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Dog Vaccine Report?

Have a Query? Click Here

Other Related Reports

Eyedrops Comprehensive Study by Type (Artificial tears, Allergy drops, Anti-redness drops), Application (Glaucoma, Eye Infections, Allergies, Dry Eyes, Others), Nature (Natural, Homeopathic, Herbal),...
$ 3650
Isosorbide Mononitrate Comprehensive Study by Type (10 mg Tablet, 20 mg Tablet), Application (Angina Pectoris, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies...
$ 3500
Bisphosphonate Drug Comprehensive Study by Type (Alendronate, Etidronate, Risedronate, Zoledronic Acid), Application (Post-menopausal osteoporosis, Bone Loss caused by Cancer Treatment, Complex Regio...
$ 3650
Aneurysmal Subarachnoid Hemorrhage Drugs Comprehensive Study by Type (Opioid Analgesic, Calcium Channel Blocker, Anticonvulsant, Stool Softener, Osmotic Agent, Other Drugs), End User (Hospitals, Clin...
$ 3500
Opioids Agonist Drugs Comprehensive Study by Type (Morphine, Codeine, Fentanyl, Meperidine), Application (Pain Management, Cough Supression, Diarrhea Suppresion), Receptor Binding (Strong Agonist, Mi...
$ 3350
Citicoline Comprehensive Study by Form (Tablet, Capsule, Powder), Indication (Alzheimer’s Disease, Dementia, Head Trauma, Cerebral Ischemic Stroke, Cognitive Impairment, Others), Distribution (Hospit...
$ 3650